Cost-Effectiveness of Ultrasound Renal Denervation for Resistant Hypertension in Belgium, France and The Netherlands
The addition of endovascular uRDN offers clinicians and payers a cost-effective adjunctive treatment approach alongside hypertensive medication for the management of rHTN in the healthcare systems of Belgium, France and the Netherlands.
Authors
- S.K. Carter
- Sofie Brouwers (ORCID: https://orcid.org/0000-0002-7081-4881)
- R. S. Taylor (ORCID: https://orcid.org/0000-0002-3043-6011)
- Ajay Jayant Kirtane (ORCID: https://orcid.org/0000-0003-0061-1058)
- Isabelle Durand‐Zaleski (ORCID: https://orcid.org/0000-0002-4078-1476)
- Kieran J. Murphy (ORCID: https://orcid.org/0000-0002-5191-3569)
- Linh B. Ngo (ORCID: https://orcid.org/0000-0002-9889-2742)
- Michel Azizi
- Kaylie Metcalfe
- Joost Daemen
- Antoine Cremer
- Marie-Claude Morice
Institutions
- NewYork–Presbyterian Hospital (US)
- Vrije Universiteit Brussel (BE)
- Inserm (FR)
- Université Paris-Est Créteil (FR)
- Université Paris Cité (FR)
- New York Hospital Queens (US)
- Erasmus MC (NL)
- Cardiovascular European Research Center (FR)
- Sorbonne Paris Cité (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Onze Lieve Vrouwziekenhuis Hospital (BE)
- Hôpital Européen Georges-Pompidou (FR)
- Hôpital Européen (FR)
- Hôpital Saint-André (FR)
- MRC/CSO Social and Public Health Sciences Unit (GB)
- Flanders Environment Agency (BE)
- Centre de Recherche Épidémiologie et Statistique (FR)
- Columbia University (US)
Publication Details
- Journal
- PharmacoEconomics - Open
- Published
- 2025-04-16
- DOI
- https://doi.org/10.1007/s41669-025-00574-2
- Citations
- 3
- Primary Topic
- Blood Pressure and Hypertension Studies
- Type
- article
- Field-Weighted Citation Impact
- 4.16
Funders
- ReCor Medical